L-365,260, a Potent CCK-B/Gastrin Receptor Antagonist, Suppresses Gastric Acid Secretion Induced by Histamine and Bethanechol as Well as Pentagastrin in Rats.
スポンサーリンク
概要
- 論文の詳細を見る
We evaluated the effects of a potent cholecystokinin (CCK)-B/gastrin receptor antagonist, L-365, 260 (3<I>R</I>(+)-<I>N</I>-(2, 3-dihydro-1-methyl-2-oxo-5-phenyl-1<I>H</I>-1, 4-benzodiazepin-3-yl)-<I>N''</I>-(3-methylphenyl)urea); a selective CCK-A receptor antagonist, devazepide (L-364, 718); and cimetidine on gastric acid secretion induced by pentagastrin, histamine and bethanechol in anesthetized rats. We also evaluated the effects of L-365, 260 and cimetidine on acid secretion in pylorus-ligated rats. Intravenous administration of L-365, 260, L-364, 718 and cimetidine dose-dependently reduced acid secretion induced by pentagastrin (20 nmol/kg/hr), with ED<SUB>50</SUB> values of 0.63, 19.1 and 2.5 μmol/kg, respectively. Of interest was the finding that L-365, 260, like cimetidine, dose-dependently inhibited acid secretion induced by histamine (100 μmol/kg/hr) and bethanechol (5 μmol/kg/hr) with ED<SUB>50</SUB> values of 5.9 and 4.3 μmol/kg, respectively. L-364, 718, even at 30 μmol/kg, i.v., had only a slight effect on histamine or bethanechol-induced acid secretion. Gastric acid secretion was suppressed by treatment with L-365, 260 (3-100 μmol/kg, i.v.) and cimetidine (11.9-396.4 μmol/kg, i.v.) in pylorus-ligated rats, with ED<SUB>50</SUB> values of 13.3 and 96.9 μmol/kg, respectively. These results indicate that L-365, 260 suppresses acid secretion induced by histamine and bethanechol in rats and that the gastrin receptor plays an important role in acid secretion in pylorus-ligated rats.
- 公益社団法人 日本薬理学会の論文
著者
-
Ito Hiroyuki
Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
Yuki Hidenobu
Medicinal Research Laboratories 1, Central Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Kamato Takeshi
Medicinal Research Laboratories 1, Central Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Miyata Keiji
Medicinal Research Laboratories 1, Central Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Yamano Mayumi
Medicinal Research Laboratories 1, Central Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Honda Kazuo
Medicinal Research Laboratories 1, Central Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Kamato Takeshi
Medicinal Research Laboratories I, Central Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Nishida Akito
Medicinal Research Laboratories I, Central Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Tsutsumi Rie
Medicinal Research Laboratories I, Central Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Yamano Mayumi
Medicinal Research Laboratories I, Central Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Ito Hiroyuki
Medicinal Research Laboratories 1, Central Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Ito Hiroyuki
Medicinal Research Laboratories I, Central Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Honda Kazuo
Medicinal Research Laboratories I, Central Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
関連論文
- Influenza-induced Rhabdomyolysis after Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma
- Antiemetic Effects of YM060, a Potent and Selective Serotonin (5HT)3-Receptor Antagonist, in Ferrets and Dogs.
- L-365,260, a Potent CCK-B/Gastrin Receptor Antagonist, Suppresses Gastric Acid Secretion Induced by Histamine and Bethanechol as Well as Pentagastrin in Rats.